Portage Biotech ROCE 2024

Portage Biotech Aktienanalyse

What does Portage Biotech do?

Portage Biotech Inc is an international biotechnology company based in Canada. The company was established in 2015 as a holding company and took control of the stock of Biohaven Pharmaceutical Holding Company. Portage Biotech operates in various locations, including Canada, the US, and Europe. The business model of Portage Biotech is based on identifying promising new technologies and creating companies that utilize these technologies. The company employs a strategic investment strategy, acquiring stakes in promising biotechnology companies and working closely with them to bring their products and therapies to market. Another strategy of Portage Biotech is the establishment of innovation centers in different countries. This involves bringing together highly skilled personnel and cutting-edge technologies under one roof to create innovative products and solutions that can be brought to the global market. The company also operates in several business areas, including medical research and development. In this field, Portage Biotech works on developing new therapies, particularly in the field of cancer research. Additionally, the company has a division for medical diagnostics, where innovative testing procedures are developed to contribute to early disease detection. Another important business area for Portage Biotech is the manufacturing of biopharmaceuticals, which are drugs based on biological agents. The company collaborates closely with other biotechnology companies to bring innovative products to the market. Portage Biotech has already successfully implemented a number of promising projects, including the development of therapies for cancer, Alzheimer's, and Parkinson's. The company also has promising biosimilars and biosuperior products in the pipeline that could revolutionize the market. To successfully execute these projects, Portage Biotech has assembled an impressive leadership team. The company has an experienced team of scientists, managers, and professionals who are dedicated to finding the best solutions for the challenges of the biotechnology industry. Overall, Portage Biotech is an innovative company that focuses on the discovery and promotion of promising new technologies. The company has already achieved an impressive track record and has the potential to play a revolutionary role in the field of biotechnology. Portage Biotech ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Portage Biotech's Return on Capital Employed (ROCE)

Portage Biotech's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Portage Biotech's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Portage Biotech's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Portage Biotech’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Portage Biotech stock

What is the ROCE (Return on Capital Employed) of Portage Biotech this year?

The ROCE of Portage Biotech is -4.54 undefined this year.

How has the ROCE (Return on Capital Employed) of Portage Biotech developed compared to the previous year?

The ROCE of Portage Biotech has increased by 3,428.16% increased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Portage Biotech?

A high Return on Capital Employed (ROCE) indicates that Portage Biotech has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Portage Biotech?

A low ROCE (Return on Capital Employed) can indicate that Portage Biotech has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Portage Biotech impact the company?

An increase in the ROCE of Portage Biotech can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Portage Biotech affect the company?

A decrease in ROCE of Portage Biotech can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Portage Biotech?

Some factors that can affect Portage Biotech's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Portage Biotech so important for investors?

The ROCE of Portage Biotech is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Portage Biotech take to improve the ROCE?

To improve the ROCE, Portage Biotech can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Portage Biotech pay?

Over the past 12 months, Portage Biotech paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Portage Biotech is expected to pay a dividend of 0 USD.

What is the dividend yield of Portage Biotech?

The current dividend yield of Portage Biotech is .

When does Portage Biotech pay dividends?

Portage Biotech pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Portage Biotech?

Portage Biotech paid dividends every year for the past 0 years.

What is the dividend of Portage Biotech?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Portage Biotech located?

Portage Biotech is assigned to the 'Health' sector.

Wann musste ich die Aktien von Portage Biotech kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Portage Biotech from 10/2/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/2/2024.

When did Portage Biotech pay the last dividend?

The last dividend was paid out on 10/2/2024.

What was the dividend of Portage Biotech in the year 2023?

In the year 2023, Portage Biotech distributed 0 USD as dividends.

In which currency does Portage Biotech pay out the dividend?

The dividends of Portage Biotech are distributed in USD.